Loyal

The COO will own the operational execution of the company's first commercial launch in 2027, managing Finance, People, Engineering, and Commercial functions. They are responsible for scaling the organization from 70 to 150 people using AI-leveraged efficiency and managing the internal operating cadence.

Lead the design, execution, and strategic direction of clinical programs for veterinary longevity drugs. Drive end-to-end clinical strategy from target product profiles to regulatory-facing protocol development and evidence package generation.

Build and lead the company's finance, accounting, and business operations infrastructure to scale the organization toward commercial launch. Act as a strategic partner to the CEO by driving capital strategy, fundraising, and board reporting.

The Director will serve as the subject matter expert for FDA CVM regulatory strategy, leading clinical trial operations and agency interactions. They will oversee regulatory submissions, provide guidance on clinical studies, and manage a team to ensure compliance and strategic alignment.

The Sales Executive will independently manage the full sales cycle for deals ranging from $150K–$800K ARR, focusing on strategic customer acquisition within large health systems. Responsibilities include owning client relationships, applying in-depth product knowledge to address customer needs, and mentoring junior team members.